Literature DB >> 25255824

Stereochemistry of mephedrone neuropharmacology: enantiomer-specific behavioural and neurochemical effects in rats.

Ryan A Gregg1, Michael H Baumann, John S Partilla, Julie S Bonano, Alexandre Vouga, Christopher S Tallarida, Venkata Velvadapu, Garry R Smith, M Melissa Peet, Allen B Reitz, S Stevens Negus, Scott M Rawls.   

Abstract

BACKGROUND AND
PURPOSE: Synthetic cathinones, commonly referred to as 'bath salts', are a group of amphetamine-like drugs gaining popularity worldwide. 4-Methylmethcathinone (mephedrone, MEPH) is the most commonly abused synthetic cathinone in the UK, and exerts its effects by acting as a substrate-type releaser at monoamine transporters. Similar to other cathinone-related compounds, MEPH has a chiral centre and exists stably as two enantiomers: R-mephedrone (R-MEPH) and S-mephedrone (S-MEPH). EXPERIMENTAL APPROACH: Here, we provide the first investigation into the neurochemical and behavioural effects of R-MEPH and S-MEPH. We analysed both enantiomers in rat brain synaptosome neurotransmitter release assays and also investigated their effects on locomotor activity (e.g. ambulatory activity and repetitive movements), behavioural sensitization and reward. KEY
RESULTS: Both enantiomers displayed similar potency as substrates (i.e. releasers) at dopamine transporters, but R-MEPH was much less potent than S-MEPH as a substrate at 5-HT transporters. Locomotor activity was evaluated in acute and repeated administration paradigms, with R-MEPH producing greater repetitive movements than S-MEPH across multiple doses. After repeated drug exposure, only R-MEPH produced sensitization of repetitive movements. R-MEPH produced a conditioned place preference whereas S-MEPH did not. Lastly, R-MEPH and S-MEPH produced biphasic profiles in an assay of intracranial self-stimulation (ICSS), but R-MEPH produced greater ICSS facilitation than S-MEPH. CONCLUSIONS AND IMPLICATIONS: Our data are the first to demonstrate stereospecific effects of MEPH enantiomers and suggest that the predominant dopaminergic actions of R-MEPH (i.e. the lack of serotonergic actions) render this stereoisomer more stimulant-like when compared with S-MEPH. This hypothesis warrants further study.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25255824      PMCID: PMC4301696          DOI: 10.1111/bph.12951

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  54 in total

1.  The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue.

Authors:  Michael H Baumann; Mario A Ayestas; John S Partilla; Jacqueline R Sink; Alexander T Shulgin; Paul F Daley; Simon D Brandt; Richard B Rothman; Arnold E Ruoho; Nicholas V Cozzi
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

Review 2.  Designer drugs: a medicinal chemistry perspective.

Authors:  F Ivy Carroll; Anita H Lewin; S Wayne Mascarella; Herbert H Seltzman; P Anantha Reddy
Journal:  Ann N Y Acad Sci       Date:  2011-11-17       Impact factor: 5.691

3.  Mephedrone (4-methylmethcathinone) and intracranial self-stimulation in C57BL/6J mice: comparison to cocaine.

Authors:  J Elliott Robinson; Abigail E Agoglia; Eric W Fish; Michael C Krouse; C J Malanga
Journal:  Behav Brain Res       Date:  2012-06-21       Impact factor: 3.332

4.  4-Methylmethcathinone (mephedrone): neuropharmacological effects of a designer stimulant of abuse.

Authors:  Gregory C Hadlock; Katy M Webb; Lisa M McFadden; Pei Wen Chu; Jonathan D Ellis; Scott C Allen; David M Andrenyak; Paula L Vieira-Brock; Christopher L German; Kevin M Conrad; Amanda J Hoonakker; James W Gibb; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  J Pharmacol Exp Ther       Date:  2011-08-02       Impact factor: 4.030

5.  Mephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake rats.

Authors:  J Kehr; F Ichinose; S Yoshitake; M Goiny; T Sievertsson; F Nyberg; T Yoshitake
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

6.  Mephedrone, new kid for the chop?

Authors:  Adam R Winstock; Luke R Mitcheson; Paolo Deluca; Zoe Davey; Ornella Corazza; Fabrizio Schifano
Journal:  Addiction       Date:  2010-08-23       Impact factor: 6.526

7.  Mephedrone: use, subjective effects and health risks.

Authors:  Adam Winstock; Luke Mitcheson; John Ramsey; Susannah Davies; Malgorzata Puchnarewicz; John Marsden
Journal:  Addiction       Date:  2011-07-27       Impact factor: 6.526

8.  Instability of the ecstasy market and a new kid on the block: mephedrone.

Authors:  Tibor M Brunt; Anneke Poortman; Raymond J M Niesink; Wim van den Brink
Journal:  J Psychopharmacol       Date:  2010-09-08       Impact factor: 4.153

9.  Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats.

Authors:  Craig P Motbey; Glenn E Hunt; Michael T Bowen; Suzanne Artiss; Iain S McGregor
Journal:  Addict Biol       Date:  2011-10-13       Impact factor: 4.280

Review 10.  Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.

Authors:  Fabrizio Schifano; Antonio Albanese; Suzanne Fergus; Jackie L Stair; Paolo Deluca; Ornella Corazza; Zoe Davey; John Corkery; Holger Siemann; Norbert Scherbaum; Magi' Farre'; Marta Torrens; Zsolt Demetrovics; A Hamid Ghodse
Journal:  Psychopharmacology (Berl)       Date:  2010-11-12       Impact factor: 4.530

View more
  35 in total

1.  Chemokine CCR5 and cocaine interactions in the brain: Cocaine enhances mesolimbic CCR5 mRNA levels and produces place preference and locomotor activation that are reduced by a CCR5 antagonist.

Authors:  Sunil U Nayak; Stephanie Cicalese; Chris Tallarida; Chicora F Oliver; Scott M Rawls
Journal:  Brain Behav Immun       Date:  2019-09-23       Impact factor: 7.217

2.  Synthetic cathinone MDPV downregulates glutamate transporter subtype I (GLT-1) and produces rewarding and locomotor-activating effects that are reduced by a GLT-1 activator.

Authors:  Ryan A Gregg; Callum Hicks; Sunil U Nayak; Christopher S Tallarida; Paul Nucero; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Neuropharmacology       Date:  2016-04-13       Impact factor: 5.250

3.  Synthetic cathinone MDPV enhances reward function through purinergic P2X7 receptor-dependent pathway and increases P2X7 gene expression in nucleus accumbens.

Authors:  Taylor A Gentile; Steven J Simmons; Christopher S Tallarida; Shu Su; Slava Rom; Mia N Watson; Allen B Reitz; Raghava Potula; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2019-01-31       Impact factor: 4.492

4.  Structure-Activity Relationships of Synthetic Cathinones.

Authors:  Richard A Glennon; Małgorzata Dukat
Journal:  Curr Top Behav Neurosci       Date:  2017

5.  Effects of dopaminergic and serotonergic compounds in rats trained to discriminate a high and a low training dose of the synthetic cathinone mephedrone.

Authors:  Iman Saber; Andrew Milewski; Allen B Reitz; Scott M Rawls; Ellen A Walker
Journal:  Psychopharmacology (Berl)       Date:  2019-04-13       Impact factor: 4.530

6.  Stereochemistry and neuropharmacology of a 'bath salt' cathinone: S-enantiomer of mephedrone reduces cocaine-induced reward and withdrawal in invertebrates.

Authors:  Alexandre Vouga; Ryan A Gregg; Maryah Haidery; Anita Ramnath; Hassan K Al-Hassani; Christopher S Tallarida; David Grizzanti; Robert B Raffa; Garry R Smith; Allen B Reitz; Scott M Rawls
Journal:  Neuropharmacology       Date:  2014-12-09       Impact factor: 5.250

7.  Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Curr Top Behav Neurosci       Date:  2017

8.  Chemokines and cocaine: CXCR4 receptor antagonist AMD3100 attenuates cocaine place preference and locomotor stimulation in rats.

Authors:  Jae Kim; Krista L Connelly; Ellen M Unterwald; Scott M Rawls
Journal:  Brain Behav Immun       Date:  2016-08-26       Impact factor: 7.217

9.  Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats.

Authors:  Blake A Hutsell; Michael H Baumann; John S Partilla; Matthew L Banks; Rakesh Vekariya; Richard A Glennon; S Stevens Negus
Journal:  Eur Neuropsychopharmacol       Date:  2015-12-11       Impact factor: 4.600

10.  Stereoselective Differences between the Reinforcing and Motivational Effects of Cathinone-Derived 4-Methylmethcathinone (Mephedrone) In Self-Administering Rats.

Authors:  Helene L Philogene-Khalid; Steven J Simmons; Sunil Nayak; Rose M Martorana; Shu H Su; Yohanka Caro; Brona Ranieri; Kathryn DiFurio; Lili Mo; Taylor A Gentile; Ali Murad; Allen B Reitz; John W Muschamp; Scott M Rawls
Journal:  ACS Chem Neurosci       Date:  2017-09-22       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.